グローバルヘルスと企業戦略: 多様かつ革新的なパートナーシップ・モデル Global Health and Corporate Strategy: Diverse, Innovative Partnership Models 2012年10月11日 October 11 th , 2012 富士フイルム株式会社 東京ミッドタウン本社2階 カンファレンスルーム Fujifilm Corporation / Midtown West Conference room (2F) 後援:外務省 Supported by: the Ministry of Foreign Affairs of Japan 協力:特定非営利活動法人 日本リザルツ In cooperation with: RESULTS Japan
12
Embed
グローバルヘルスと企業戦略: 多様かつ革新的なパートナーシッ … · 17:40-17:55 Wrap Up - Dr. Seth Berkley (CEO, GAVI Alliance) - Dr. Tadataka Yamada (Member
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
グローバルヘルスと企業戦略: 多様かつ革新的なパートナーシップ・モデル
Global Health and Corporate Strategy:
Diverse, Innovative Partnership Models
2012年10月11日
October 11th, 2012
富士フイルム株式会社 東京ミッドタウン本社2階 カンファレンスルーム
Fujifilm Corporation / Midtown West Conference room (2F)
後援:外務省 Supported by: the Ministry of Foreign Affairs of Japan
協力:特定非営利活動法人 日本リザルツ In cooperation with: RESULTS Japan
<Summary> We are pleased to inform you that GAVI Alliance, HGPI and UNICEF Tokyo Office will hold a collaborative Symposium entitled “Global Health and Corporate Strategy: Diverse, Innovative Partnership Models” on Thursday, October 11, 2012. In this symposium we will focus on the benefits of partnership, and both the barriers and strategic approaches involved, through sharing stories of successful solutions to global health challenges achieved by corporate partnerships. We are particularly aiming to explore the potential for taking diverse approaches that utilize the unique characteristics of each corporation, thus making a more meaningful impact and contribution to international society.
Program
15:00-15:10 Opening Remarks Dr. Seth Berkley (CEO, GAVI Alliance)
15:10-15:25 Keynote Speech 1 Dr. Kiyoshi Kurokawa (Chairman, HGPI)
15:25-15:40 Keynote Speech 2 Dr. Tadataka Yamada (Member of the Board, Chief Medical & Scientific Officer, Takeda Pharmaceutical Company Limited)
15:40-16:00 Break
16:00-17:40 Panel Discussion
Moderator: Mr. Koichi Kaneda (Senior Director, Corporate Social Responsibility, Corporate Communication Dept., Takeda Pharmaceutical Company Limited)
“Partnership Case Study -- Ghana Project --” Dr. Yasuhiko Toride (Director of Nutrition Improvement Projects / Associate General Manager, R&D Planning Dept., Ajinomoto Co., Inc)
“Partnership Case Study --Anti-Infective Drug--” Dr. Junichi Mitsuyama (Senior Operations Manager, FUJIFILM Corporation/Director, Toyama Chemical Co., Ltd.)
"Partnership Case Study --Vaccine & Medicine Development for NTDs through Partnership--“ Dr. BT Slingsby (Director of Global Access Strategies, Eisai Co., Ltd.)
“Partnership Case Study --Vaccine Bonds--” Mr. Satoru Yamamoto (Director, Head of International Investors Services, FICC Sales Dept (I), Daiwa Securities Co.Ltd.)
“Seeking Multi-Stakeholder Partnerships” Dr. Kunihiko Chris Hirabayashi (Director, United Nations Children's Fund Tokyo office)
17:40-17:55 Wrap Up
- Dr. Seth Berkley (CEO, GAVI Alliance) - Dr. Tadataka Yamada (Member of the Board, Chief Medical & Scientific Officer, Takeda Pharmaceutical Company Limited) - Dr. Kiyoshi Kurokawa (Chairman, HGPI)
17:55-18:00 Closing Remarks Dr. Shiro Konuma (Director, Global Health Policy Division International Cooperation Bureau
Ministry of Foreign Affairs)
Date: Thursday, October 11, 2012 from 15:00~18:00(Doors open at 14:30) Venue: Fujifilm Corporation / Midtown West Conference room(2F) Co-organizers: GAVI Alliance/ Health and Global Policy Institute (HGPI)/ UNICEF Tokyo Office Supported by: the Ministry of Foreign Affairs of Japan In cooperation with: RESULTS Japan ※ English-Japanese (Simultaneous interpretation will be provided)
Global Health and Corporate Strategy: Diverse, Innovative Partnership Models
ご登壇者のご紹介 / Introduction of Speakers
黒川 清 政策研究大学院大学アカデミックフェロー、Health and Global Policy Institute 代表理事 Chair and Founder, IMPACT Foundation Japan、東京大学名誉教授 東京大学医学部卒業。69年に渡米、79年UCLA内科教授。83年帰国後、東京大学内科教授、東海大学医学部長、日本学術会議会長、内閣府総合科学技術会議議員(2003-07年)、内閣特別顧問(2006-08年)、WHOコミッショナー(2005-09年)などを歴任。国際科学者連合体の役員など幅広い分野で活躍。現在、MIT、コロンビア大学客員研究員。著書『世界級キャリアのつくり方』他。http://www.kiyoshikurokawa.com/
Kiyoshi Kurokawa Professor, National Graduate Institute for Policy Studies / Chairman, Health and Global Policy Institute Chair, Co-Founder, IMPACT Japan A graduate of University of Tokyo Faculty of Medicine; in US 1969-85, was a professor of medicine, School of Medicine of UCLA (1979-84), of University of Tokyo (1989-96), Dean of Tokai University School of Medicine (1996-2002), President of Science Council of Japan (2003-06), Science Advisor to the Prime Minister (2006-08). Executive member of many national and international professional societies, WHO Commissioner (2005-09), Institute of Medicine of National Academies of Sciences of USA. His website: <http://www.kiyoshikurokawa.com/en>
セス・バークレー GAVIアライアンス 事務局長 2011年8月GAVIアライアンス事務局長就任。同年、GAVIアライアンスは2015年までに途上国の10億人の子どもの25%に予防接種を受けさせるとする5年戦略を開始。同アライアンスの前は、官民パートナーシップによる初のワクチン開発イニチアチブである国際エイズワクチン推進構想(International AIDS Vaccine Initiative: IAVI)を設立し、15年間代表を務める。
Seth Berkley Chief Executive Officer, the GAVI Alliance Seth Berkley joined the GAVI Alliance as CEO in August 2011, as it launched its five year strategy to immunise a quarter of a billion children in the developing world with life-saving vaccines by 2015. Prior to joining the GAVI Alliance, Seth was the founder, president and CEO for 15 years of the International AIDS Vaccine Initiative ( IAVI ), the first vaccine product development public-private sector partnership. Prior to founding IAVI, Seth served as associate director in the Health Sciences Division at The Rockefeller Foundation. He has also worked for the Center for Infectious Diseases of the U. S. Centers for Disease Control and Prevention ( CDC ), the Massachusetts Department of Public Health and for the Carter Center where he served as an epidemiologist at the Ministry of Health in Uganda. Seth received his undergraduate and medical degrees from Brown University and trained in internal medicine at Harvard University.
Tadataka Yamada Member of the Board, Chief Medical & Scientific Officer, Takeda Pharmaceutical Company Limited Dr. Tadataka (Tachi) Yamada is Executive Vice-President of Takeda Pharmaceuticals International, Inc. He is a Board Member and chairs the Corporate Management Operating Committee which oversees all investments in research and development, business development and in-licensing of Takeda Pharmaceutical Company Limited. He serves as Chief Medical and Scientific Officer of Takeda Pharmaceutical Company Limited. and Takeda Pharmaceuticals International, Inc. He was formerly President of the Bill & Melinda Gates Foundation Global Health Program. In this capacity he oversaw grants totaling over $9 billion in programs directed at applying technologies to address major health challenges of the developing world including TB, HIV, malaria and other infectious diseases, malnutrition and maternal and child health. Before joining the Gates Foundation Dr. Yamada was Chairman, Research and Development and a Member of the Board of Directors of GlaxoSmithKline. Before joining GlaxoSmithKline, he was Chairman, Department of Internal Medicine and Physician-in-Chief of the University of Michigan Medical Center. He graduated from Stanford University with a BA in history and obtained his M.D. from New York University School of Medicine. Dr. Yamada was born in Japan, and completed his education in the United States.
Koichi Kaneda Senior Director, Corporate Social Responsibility, Corporate Communication Dept., Takeda Pharmaceutical Company Limited Mr. Kaneda graduated from the Faculty of Economics, Keio University in 1987 and completed his master’s course at the Graduate School of Economics, Reading University in 1993. His professional experiences include the external relations department at SONY Corporation, the Economic Section at the U.S. Embassy in Tokyo (as an officer in charge of economic and trade policy), the Bloomberg TV (as a broadcaster), and the Graduate School of Media and Governance, Keio University (as a part-time lecturer) from 2007 to 2008. Mr. Kaneda started to promote CSR programs at SONY Corporation in 1999, then at Daiwa Securities Group Inc., and is currently promoting CSR activities at Takeda Pharmaceutical Company Limited. He is also active as a member of the “New Public Commons” Roundtable under the Cabinet Office, a member of Japan NPO Research Association, a member of Japan Association for Human Security Studies, and the advisor of Japan Platform.
BT Slingsby Director , Global Access Strategies, Eisai Co., Ltd. Dr. Slingsby is Director of Global Access Strategies at Eisai Co., Ltd. Global Access Strategies is dedicated to the implementation of new partnership-based business models that improve access to medicines, the creation of product development partnerships for new medicines that target diseases of the developing world, and the management of Eisai’s partnership with the WHO in the elimination of lymphatic filariasis. Before joining Eisai, he was involved in the founding of for-profit and non-profit entities in the US and Japan and was active in healthcare research, with over 50 published peer-reviewed articles in journals including the Lancet, Journal of Public Health, and the Journal of General Internal Medicine. Dr. Slingsby graduated from Brown University, earned his Masters and Doctorate from Kyoto University, The University of Tokyo, and received his Medical Doctorate from The George Washington University.
Junichi Mitsuyama Senior Operations Manager, FUJIFILM Corporation / Director, Toyama Chemical Co., Ltd. Dr. Mitsuyama joined Toyama Chemical Co., Ltd. in 1983. During his service at the company, he also worked at the Department of Microbiology and Molecular Genetics, Graduate School of Pharmaceutical Science, Chiba University from April 1984 to March 1985, and then at the Department of Microbiology, Graduate School of Medicine, Toho University from July 1993 to March 1994. He was certified as an infection control doctor (ICD) in 2006 and has served as a part-time lecturer at the Medical Mycology Research Center, Chiba University since 2011. Dr. Mitsuyama received a doctor of medicine degree at Toho University, and is currently a member of the Japanese Society for Chemotherapy (as a counselor), the Japanese Society for Clinical Microbiology, the Japanese Society for Bacteriology, and the Japanese Society of Parasitology.
Yasuhiko Toride Director, Nutrition Improvement Projects / Associate General Manager, R&D Planning Dept., Ajinomoto Co., Inc. Dr. Yasuhiko Toride finished his master’s course in Agricultural Chemistry at the University of Tokyo in 1981 and joined Ajinomoto Co., Inc. While working at the company, he was involved in development, TS, and sales of amino acids for animal feed, new product development at the laboratories, and conducted nutrition improvement tests using Lysine in countries including China and Syria. From 1986 to 1992 he worked at Ajinomoto Co., (Thailand) Ltd. From 2005 to 2009 he worked at Ajinomoto Europe (France), where he managed overall research & development in Europe. Dr.Toride assumed his present post at R&D Planning Department of Ajinomoto Co., Inc. in 2009 and has been promoting nutrition improvement projects in developing nations. He earned a Ph.D in agriculture from the University of Tokyo.
Shiro Konuma Director, Global Health Policy Division, the Ministry of Foreign Affairs of Japan Dr. Shiro Konuma is currently Director of Global Health Policy Division at the Ministry of Foreign Affairs of Japan. He graduated from Faculty of Medicine, the University of Tokyo in 1992 and worked for the University of Tokyo Hospital until joining Japanese diplomatic service in 1994. In 1996, he studied at INSEAD in France. Prior to his current assignment, he was Counsellor of the Permanent Mission of Japan in Geneva, responsible for development and macro-economic issues in the WTO and other trade related organizations.
Kuniiko Chris Hirabayashi Director, UNICEF Tokyo Office Dr. Kunihiko Chris Hirabayashi assumed his duties as Director of UNICEF Tokyo in April 2010. Prior to this appointment, Dr. Hirabayashi served as Deputy Representative of UNICEF India from 2008. Prior to this, he worked as Senior Programme Advisor to the Ministry of Public Health Afghanistan, Senior Project Officer, Chief of Health and Nutrition Section at UNICEF Afghanistan, Chief of Health and Nutrition Emergency Programme at UNICEF Lebanon and Senior Programme Manager of UNICEF Tokyo Office. Before joining UNICEF, Dr. Hirabayashi worked as Technical advisor for Center for International Medical Cooperation, International Medical Center of Japan, Ministry of Health, Labor and Welfare and extended technical assistance to many developing countries such as Bolivia, Colombia, India, Indonesia, Honduras, Uzbekistan, South Africa and Vietnam for about 10 years since 1994. He earned M.D. and Ph.D. in medicine from University of Tsukuba, Japan.
に国際金融公社と協働で日本初のマイクロファイナンス・ボンドを立ち上げ、日本初のマイクロファイナンス投資信託である大和マイクロファイナンス・ファンド(2011年3月設定)の開発・プロモーションにも携わる。その他、IFFImワクチン債、世界銀行ワールド・クールボンド、世界銀行グリーンボンド、などを担当。アジア・イノベーション・フォーラム(2010年9月)、JICA IRセミナー(2011年11月)、TEDxKyotoChange(2012年4月)など、カンファレンス登壇実績多数。2012年3月には、ダボス会議を主催する世界経済フォーラムよりYoung Global Leaders for 2012の一人に選出される。2012年7月より現職。慶應義塾大学経済学部卒。米UC BerkeleyにてMBA取得。
Satoru Yamamoto Director, Head of International Investors Services, FICC Sales Dept (I), Daiwa Securities Co., Ltd. Mr. Yamamoto is currently responsible for Daiwa’s fixed income sales for international institutional investors. Before joining the team this July, he had led Daiwa’s “Impact Investing” initiatives, including IFFIm Vaccine Bonds, World Bank World CO2LTM Bond, World Bank Green Bond and the Daiwa Microfinance Fund. Prior to the responsibility of product planning & development for retail investors since 2001 to July 2012, he was responsible for sales planning at Daiwa’s headquarter. He started his carrier at Daiwa’s Kagoshima branch office as a sales consultant in 1998. He frequently appears at international conferences, including the Microfinance Investments in Asia (January 2010), the TBLI Conference ASIA (June 2010), the JCIE symposium “Challenges in Global Health: New Opportunities for the Private Sector” (July 2010), Asia Innovation Forum (September 2010 and TEDxKyoto Change(April 2012). He holds MBA from Haas School of Business at University of California, Berkeley (USA) and BA in Economics from Keio University (Japan). He has been named a Young Global Leader for 2012 by the World Economic Forum.
GAVI Alliance www.gavialliance.org The GAVI Alliance is a public-private global health partnership committed to saving children’s lives and protecting people’s health by increasing access to immunisation in poor countries. The Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry in both industrialised and developing countries, research and technical agencies, civil society organisations, the Bill & Melinda Gates Foundation and other private sector partners. Since it was launched at the World Economic Forum in 2000, GAVI has prevented more than 5.5 million future deaths and helped protect 325 million children with new and underused vaccines.
Health and Global Policy Institute www.hgpi.org/en/ Since its establishment in 2004, the Health and Global Policy Institute (HGPI) has been working to help interested citizens shape health policy by generating policy options and bringing stakeholders together as a nonpartisan think tank. HGPI’s mission is to improve civic and individual well-being and to foster a sustainable, healthy community by shaping ideas and values, reaching out to global needs, and catalyzing society for impact. HGPI commits to activities that bring together relevant players in different fields to provide innovative and practical solutions and help interested citizens understand choices and benefits from a global, long-term perspective. HGPI promotes global citizenship by building a society for people possessing diverse backgrounds and holding different values. It aims to achieve a sustainable, healthy, and more prosperous world.
UNICEF Tokyo Office The United Nations Children’s Fund (UNICEF) was created by the United Nations on December 1946, to provide emergency food and healthcare to children in countries that had been devastated by World War II. UNICEF has been since the driving force that helps build a world, where the rights of every child are realized, providing health care and immunizations, clean water and sanitation, nutrition, education, emergency relief, and policy advocacy with a presence in more than 160 countries and territories. To conduct such activities, UNICEF upholds the Convention on the Rights of the Child, adopted by the UN General Assembly in 1989. UNICEF Tokyo Office is tasked to strengthen its partnerships with key counterparts in Japan and South Korea, especially with government officials, parliamentarians, aid agencies and NGOs, to mobilize public-sector resources such as ODA and advocate for children’s rights.